Compare CVV & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVV | COSM |
|---|---|---|
| Founded | 1982 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 27.9M |
| IPO Year | 2007 | 2009 |
| Metric | CVV | COSM |
|---|---|---|
| Price | $4.28 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 110.3K | ★ 3.4M |
| Earning Date | 11-09-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.86 | ★ 46.15 |
| EPS | ★ 1.58 | N/A |
| Revenue | $41,128,639.00 | ★ $65,271,815.00 |
| Revenue This Year | N/A | $23.79 |
| Revenue Next Year | N/A | $37.13 |
| P/E Ratio | $2.77 | ★ N/A |
| Revenue Growth | ★ 96.27 | 19.93 |
| 52 Week Low | $2.96 | $0.16 |
| 52 Week High | $9.10 | $1.32 |
| Indicator | CVV | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 28.03 | 54.43 |
| Support Level | $3.79 | $0.27 |
| Resistance Level | $4.90 | $0.35 |
| Average True Range (ATR) | 0.20 | 0.04 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 36.62 | 38.97 |
CVD Equipment Corp designs, develops, and manufactures a broad range of equipment used to develop and produce materials and coatings for the aerospace, compound semiconductor, semiconductor, aerospace, battery energy storage markets as well as industrial applications, and research. It currently conducts its business through two reportable segments: CVD Equipment, which designs and manufactures chemical vapor deposition, physical vapor transport and thermal process equipment; and SDC, which designs and manufactures ultra-high purity gas and chemical delivery control systems. Its target markets are aerospace & defense and industrial, microelectronics / high power electronics, and EV battery materials / energy storage.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.